Simone Blank
Director/Board Member at EVOLUS, INC.
Net worth: 7 M $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Vikram Malik | M | 61 |
Crown Sterling Ltd. LLC
 Crown Sterling Ltd. LLC Packaged SoftwareTechnology Services Crown Sterling Ltd. LLC is a private company that provides a unique solution to personal data sovereignty. The company is based in Newport Beach, CA. The company offers next-generation software-based, AI-driven cryptography. The company was founded in 2018 by Robert Edward Grant, who has been the CEO since 2018.
AEON Biopharma Sub, Inc.
 AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 10 years |
| Jost Fischer | M | 69 |
SIRONA Dental Systems GmbH
 SIRONA Dental Systems GmbH Medical SpecialtiesHealth Technology Sirona Dental Systems GmbH provided dental equipment. It was a manufacturer of dental equipment, including treatment units, instruments, dental imaging systems and dental CAD/CAM systems, including the company's CEREC 3 chair side system for same-day dental restorations. The company was headquartered in Bensheim, Germany
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 19 years |
| David Moatazedi | M | 46 | 6 years | |
| Timothy Sullivan | M | 66 | 16 years | |
| Matthew Cooper | M | - | - | |
| Megan Wynne | F | - | 30 years | |
| Neville Power | M | 66 | 3 years | |
| Andrew Lusk | M | - |
Crown Sterling Ltd. LLC
Crown Sterling Ltd. LLC Packaged SoftwareTechnology Services Crown Sterling Ltd. LLC is a private company that provides a unique solution to personal data sovereignty. The company is based in Newport Beach, CA. The company offers next-generation software-based, AI-driven cryptography. The company was founded in 2018 by Robert Edward Grant, who has been the CEO since 2018. | 1 years |
| Robert Grant | M | - |
Crown Sterling Ltd. LLC
Crown Sterling Ltd. LLC Packaged SoftwareTechnology Services Crown Sterling Ltd. LLC is a private company that provides a unique solution to personal data sovereignty. The company is based in Newport Beach, CA. The company offers next-generation software-based, AI-driven cryptography. The company was founded in 2018 by Robert Edward Grant, who has been the CEO since 2018. | 6 years |
| Brady Stewart | M | 48 | 2 years | |
| Stephen Oliver Farrell | M | - | 16 years | |
| Benjamin Wyatt | M | 50 | 2 years | |
| Kurt Knab | M | - | 6 years | |
| Michael Anghie | M | - | 6 years | |
| Karah Parschauer | F | 46 | 5 years | |
| David Gill | M | 69 | 6 years | |
| Nareg Sagherian | M | - | - | |
| Robert Hayman | M | 65 | 6 years | |
| Robert Michael Melia | M | 67 | 4 years | |
| Stephen Fewster | M | - | 3 years | |
| Tomoko Yamagishi-Dressler | F | - | 1 years | |
| Peter Reynolds | M | 66 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 1 years |
| Sandra Beaver | F | 46 | 2 years | |
| Christos Monovoukas | M | - | 2 years | |
| Ed Inal | M | - |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 2 years |
| Adelbert L. Stagg | M | 77 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 5 years |
| Eric Carter | M | 72 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 1 years |
| Matthew Flood | M | - | 5 years | |
| James Wakefield | M | - | 9 years | |
| Shelley Thunen | F | 71 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 1 years |
| William Ritchie | M | - | 4 years | |
| Jessica Novak | F | - | 3 years | |
| Jeffrey J. Plumer | M | - | 10 years | |
| Chad Oh | M | 66 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 3 years |
| Dan Stewart | M | - | 3 years | |
| Rui Avelar | M | 62 | 10 years | |
| Darren O Brien | M | 48 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 1 years |
| Richard Taketa | M | 52 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 6 years |
| Robert Palmisano | M | 79 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 1 years |
| Elizabeth Betten | F | 43 | 4 years | |
| Caitriona Hayes | F | - | 5 years | |
| Peter Torre | M | 53 | - | |
| Chris Carr | M | 54 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 5 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jonathan I. Friedman | M | 53 | - | |
| Ashwin K. Agarwal | M | - | 3 years | |
| Murthy Simhambhatla | M | 58 | 2 years | |
| J. Marmo | M | 55 | - | |
| Jeffrey Slovin | M | 59 | 17 years | |
| Thomas Jetter | M | 67 | - | |
| Harry Kraemer | M | 69 | - | |
| Michael Mazen Jafar | M | 42 | 3 years | |
| Kris Garcia | M | - | - | |
| Kristine Romine | M | 59 | 2 years | |
| William K. Hood | M | 100 | - | |
| Crystal Muilenburg | F | 45 | 4 years | |
| John Sweeney | M | - | - | |
| Gregory P. Leahy | M | - | 1 years | |
| Bosun Hau | M | 45 | 2 years | |
| Theo Haar | M | 76 | 4 years | |
| Michael Stone | M | 71 | - | |
| Lauren Silvernail | F | 65 | 4 years | |
| Arthur D. Kowaloff | M | 77 | 12 years | |
| Peter Farrell | M | 81 | - | |
| David K. Erickson | M | - | - | |
| Dianne Whitfield | F | 47 | 2 years | |
| Amy Marinne Fox | F | - | 2 years | |
| Alejandro Sabad | M | - | 2 years | |
| Ulrich Michel | M | 61 | 3 years | |
| Stephan Mitsdörffer | M | 55 | - | |
| Gregory Meyerowitz | M | - | 5 years | |
| Dave K. Beecken | M | 77 | - | |
| Franz-Werner Haas | M | 54 | - | |
| Walter Petersohn | M | 57 | - | |
| Rainer Berthan | M | 60 | - | |
| David B. Schick | M | - | 12 years | |
| Nicholas Alexos | M | 60 | 6 years | |
| Tim D. Sheehan | M | 52 | 6 years | |
| Chris Guo | M | 48 | 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 63 | 80.77% |
| Australia | 16 | 20.51% |
| Germany | 1 | 1.28% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Simone Blank
- Personal Network
